Development of a Corneal Biomechanical Risk Score for Visual Field Progression in Primary Open-Angle Glaucoma
Related Experiment Video
Updated: Oct 31, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
Jinrui Zhang1,2, De-Fu Chen1,2, Chenmin Wang1,2
1National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China.
Precis:
This study developed and internally validated an exploratory risk score model based on four Corvis-ST parameters to predict visual field progression in POAG. The model demonstrated acceptable predictive and risk-stratification performance.
Purpose:
To develop a risk score model based on corneal biomechanical properties for predicting visual field (VF) progression in patients with primary open-angle glaucoma (POAG).
Methods:
This prospective clinical cohort study included POAG patients with a follow-up period exceeding 18 months and at least six reliable visual field examinations. The initial screening of relevant factors was identified using a dual-screening strategy that combined LASSO-Cox regression model and univariate Cox regression models. Then staged Cox regression models and Kaplan-Meier survival analysis were applied to evaluate the association between these factors and VF progression. Based on these analyses, a weighted integer risk score model was developed, and patients were stratified into low-risk, medium-risk, and high-risk groups.
Results:
A total of 129 patients were included, 46.5% of eyes showed progression, with a median progression time of 45 months. The final model incorporated velocity of applanation 1 (A1V), length of applanation 2 (A2L), time of applanation 2 (A2T), and pachymetry-adjusted intraocular pressure (IOP pachy). The risk score model predicted the outcome with a C-index of 0.701 (95% confidence interval [CI]: 0.620 - 0.760). It successfully stratified patients into groups with markedly different progression rates (Low: 17.2%, Medium: 45.7%, High: 76.7%; P < 0.001).
Conclusions:
This internally validated, exploratory risk score based on four corneal biomechanical parameters stratified POAG patients by risk of VF progression. Further validation is needed to determine its clinical utility.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment